Global Diabetic Neuropathy Market 2014-2018

2014-05-09
Price :
Published : May-2014
No. of Pages : 55

Report Description

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Anti-obesity Drugs Market in the US 2015-2019

Obesity is a complex multifactorial disorder characterized by the excessive accumulation and storage of fat in the body. In the recent years, this chronic illness is being considered as a global epidemic owing to its strikingly increasing incidence rates, especially in the in low and middle-income countries. Sedentary lifestyles and lack of physical activity coupled with consumption of high-calorie diet are considered to be the most preventable causes of obesity. Being either overweight or obese is considered as a risk factor for the development of multiple chronic diseases including cardiovascular disorders such as coronary heart disease, dyslipidemia, hypertension; metabolic disorders such as diabetes; and cancers to highlight a few. Although anti-obesity drugs are available in the marke......
$2500

Global Ophthalmic Therapeutic Market 2015-2019

Ophthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms at early stages. They will be painless with no defect in vision until the disease progresses to an advanced stage. Regular eye checkups must be done to detect the development of any disorder. Proper care and hygiene must be ensured to protect the eyes. The analysts forecast global ophthalmic therapeutic market to grow at a CAGR of 6.53% over the period 2014-2019. Covered in this Report The report covers the present scenario and the growth prospects of the global ophthalmi......
$3000

eHealth: Applications and Major Vendors’ Patent Deployment

In the face of an aging population and the rise of chronic diseases, governments around the world have been looking for solutions to reducing health care expenditures while maintaining medical service quality. eHealth, which provides electronic, digital, and automated medical services, is one of such solutions. This report provides an overview of eHealth applications and examines the relative R&D intensity and patent deployments of several established players in the industry, including Bosch, Medtronic, General Electric, Philips, Siemens, and Honeywell. List of Topics Overview of major eHealth applications: e-prescribing, electronic healthcare records, health information systems , mobile health, and telehealth Data mining analysis which pinpoints major technology fields and se......
$2000

Global Fibromyalgia Drugs Market 2015-2019

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, fibromyalgia is a syndrome with an unknown cause and chronic pain and muscle tenderness as the major symptoms. Unlike arthritis, it does not cause joint, muscle or other tissue inflammation. However, fibromyalgia is known to cause impairment of joints, soft tissues, and causes significant pain and fatigue. Fibromyalgia affects women more than men. In the US, the condition affects more than 5 million people aged 18 years and above, of which 80-90% are women. There is no particular diagnostic test for detecting fibromyalgia, and physicians undertake differential diagnosis to check the presence of the syndrome. Currently in the US, only three drugs are approved to treat fibromyalgia. Off-label treatment is......
$2500

Global OSDF Excipients Market 2015-2019

OSDF excipients are chemical compounds that are added along with API and other chemicals during the manufacture of a drug. The sole purpose of the excipients is to hold the components together in the different forms of oral dosage. Sometimes, these excipients also act as drug releasers by releasing controlled amount of the medication after ingestion of the same. The global OSDF excipients market has been growing at a rapid pace. North America is leading the market, followed by APAC and Europe. The North American market has witnessed growth because of the growth in aging population in the US. Though OSDF excipients are used only in oral medication drugs, the ongoing research to develop new excipients is still going on and will drive market growth further in the coming years. The pharmace......
$2500

Global Phytosterols Market 2015-2019

Phytosterols as the name implies are derived from plants. Phytosterols include plant sterols and plant stanols. These are steroid like compounds and resemble the chemical structure of cholesterols. The only differentiator is the presence of a double bond in the carbon side chain. The global phytosterols market has grown at a tremendous pace in the past few years. Europe leads the market, followed by North America. APAC is touted to be the next big market for phytosterols, backed by the growth in the emerging markets of China and India. The market for phytosterols has been segmented on the basis of application, product type, and geography. The analysts forecast global phytosterols market to grow at a CAGR of 7.65% during 2014-2019. Covered in this Report This report covers the p......
$2500

Global Clinical Trial Supply and Logistics Market 2015-2019

Clinical trial companies, also known as contact manufactures or CROs, offer development and research, and manufacturing services on a contract basis to pharmaceutical and biotechnology vendors as well as government institutions, foundations, and universities. The clinical trial industry uses outbound logistics for the complete management of the way resources are acquired, stored, and moved to different end- users or markets. The use of inbound logistics helps the clinical trial industry have a continual supply of drugs, equipment, and devices from suppliers and distributors in different locations. The analysts forecast global clinical trial supply and logistics market to grow at a CAGR of 8.87% over the period 2014-2019. Covered in this Report This report covers the present scenar......
$2500

Global Carotid Stent Market 2015-2019

Carotid artery disease refers to the blockage or narrowing of carotid arteries due to plaque formation (Fibrous tissue, cholesterol, and calcium deposits. The carotid arteries are present in the neck and supply blood to the brain. Carotid artery stenting is a minimally invasive surgical procedure used to treat carotid artery disease. The technique involves the insertion of a slender metal-mesh tube (carotid stent) through a small incision. The carotid stent expands inside a carotid artery to increase blood flow in areas blocked by plaque. Globally, 90% of carotid surgeries are performed by vascular surgeons. The analysts forecast global carotid stent market to grow at a CAGR of 13.17% over the period 2014-2019. Covered in this Report The report includes present scenario and the gr......
$2500

Global Statin Market 2015-2019

Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin. The analysts forecast global statin market to decline at a CAGR of 7.50% over the period 2014-2019. Covered in this Report This ......
$2500

Autoimmune Diseases Market in the US 2015-2019

Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some......
$2500